Cancer news

• Arsenic-based therapy may destroy leukaemia-initiating cells
  (15.05.2008)

  Scientists have discovered that the toxic element arsenic could be used to attack cells known as leukaemia-initiating cells (LICs), which are thought to drive the formation of leukaemia, and which appear to be resistant to standard cancer therapies.

• Exercise reduces the risk of breast cancer in most women
  (15.05.2008)

  Studies have shown that exercise can help to reduce the risk of breast cancer, but a new review has found that some groups of women benefit more than others.

• Scientists identify genetic changes involved in childhood cancer
  (13.05.2008)

  A new study has shed light on the genetic causes of neuroblastoma, a rare but aggressive childhood cancer that affects around 100 children a year in the UK.

• Mathematical model predicts breast tumours grow faster in younger women
  (9.05.2008)

  Norwegian researchers have published details of a new estimation method, which can be used to estimate the rate of growth of breast tumours among a population.

• Smoking death risks significantly reduced within five years of quitting
  (8.05.2008)

  Women who quit smoking have about a 20 percent lower risk of death from smoking-related cancers within five years of quitting, as well as a substantially reduced risk of death from heart disease, according to researchers at Harvard School of Public Health in Boston.

• Researchers suggest playgroups could be linked to lower leukaemia risk
  (6.05.2008)

  A new study suggests that children who attend playgroups may be less likely to develop the most common type of leukaemia. But a Cancer Research UK scientist said that a better understanding of the phenomenon was needed before advice could be given to parents.

• Healthy habits linked to higher quality of life among cancer survivors
  (6.05.2008)

  Cancer survivors who lead a healthy lifestyle are more likely to enjoy a high quality of life, US scientists have found.

• Study demonstrates drug's effect on breast cancer stem cells
  (2.05.2008)

  When used in combination with traditional chemotherapy, new 'targeted' therapies don't just kill 'normal' cancer cells, but appear to be able to target the cancer 'stem cells' from which tumour cells develop, stopping the cancer from returning, scientists have found.